SEC Form 4 · accession 0000899243-16-014603
PROTHENA CORP PUBLIC LTD CO · PRTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gene G. Kinney
Officer — CSO & Head of R&D
Period of report
Feb 24, 2016
Accepted (ET)
Feb 26, 2016 · 7:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559053
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.01 per share | holding | — | — | — | 2,793 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $34.61 | Feb 24, 2016 | A | 65,000 | A | — | Feb 24, 2026 | Ordinary Shares | 65,000 | 65,000 | D |
Explanation of responses
- F1The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 24, 2017 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.